Sign in
4

Changes in Ownership

4D Molecular Therapeutics, Inc. Filed Acc 0000950170-24-041418

Chief Legal Officer sold 8,153 shares at $31.78 ($259,102)

  • Chief Legal Officer acquired 8,153 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bizily Scott Chief Legal Officer 2024-04-01 Option exercise 10b5-1 +1,332 $6.49 $8,645 3,069 D
Bizily Scott Chief Legal Officer 2024-04-01 Option exercise 10b5-1 +2,916 $8.04 $23,445 5,985 D
Bizily Scott Chief Legal Officer 2024-04-01 Option exercise 10b5-1 +1,996 $15.78 $31,497 7,981 D
Bizily Scott Chief Legal Officer 2024-04-01 Option exercise 10b5-1 +1,909 $20.24 $38,638 9,890 D
Bizily Scott Chief Legal Officer 2024-04-01 Sale 10b5-1 −8,153 $31.78 $259,102 1,737 D
Derivatives
Bizily Scott Chief Legal Officer 2024-04-01 Option exercise · Stock Option (Right To Buy) 10b5-1 −1,332 14,711 D
Bizily Scott Chief Legal Officer 2024-04-01 Option exercise · Stock Option (Right To Buy) 10b5-1 −2,916 40,418 D
Bizily Scott Chief Legal Officer 2024-04-01 Option exercise · Stock Option (Right To Buy) 10b5-1 −1,996 21,008 D
Bizily Scott Chief Legal Officer 2024-04-01 Option exercise · Stock Option (Right To Buy) 10b5-1 −1,909 46,182 D
Open-market sales · 8,153 sh · avg $31.78 · $259,102
Loading xslF345X05/ownership.xml…